Recent trends in management of noctural enuresis
Scientific Journal of Al-Azhar Medical Faculty [Girls][The]. 2005; 26 (1): 407-415
in English
| IMEMR
| ID: emr-112386
ABSTRACT
There are many different treatment modalities for nocturnal enuresis options of treatment include behavior modification and Pharmacotherapy. The latter include a scope of drugs like 1-deamino-8-D arginine vasopressin [DDAVP], tricyclic antidepressants anticholinergics and other drugs. Is to study the efficacy of sympathomimetics [e.g. ephedrine] in the treatment of nocturnal enuresis. Two hundred patients selected after complete history, examination, laboratory, radiological and urodynamic study, those patients were given ephedrine HCL according to their age for 2 months and followed for 6 months. Complete dry bed 172 patients [86%] within the first 2 weeks of treatment and the number increased to reach 189 patients [92%] after 2 months of treatment. Eight patients [4%] complained of relapse after 3 months of stoppage of treatment and the number increased after 6 months of stoppage of treatment to 13 patients [6.5%]. Alpha sympathomimetics [ephedrine HCL] is a cheap, simple, easy, effective and safe method for nocturnal enuresis treatment
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Sympathomimetics
/
Urodynamics
/
Behavior Therapy
/
Cholinergic Antagonists
/
Deamino Arginine Vasopressin
/
Antidepressive Agents, Tricyclic
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Sci. J. Al-Azhar Med. Fac. [Girls]
Year:
2005
Similar
MEDLINE
...
LILACS
LIS